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Detecting and managing hypertension in the extended 
postnatal period  
Preventing postnatal pre-eclampsia and eclampsia
WHAT IS THE HIGH-IMPACT PRACTICE IN 
MATERNAL HEALTH?  
Measure every woman’s blood pressure after birth, 
daily until discharge and on each contact in the 
extended postnatal period. (The extended postnatal 
period is defined as 12 months following a birth).
All women should stay at a health facility for at least 24 
hours after birth. If their blood pressure (BP) was raised, 
then women should stay until their BP and other vital signs 
are normal and treated or referred [1].
If women experienced a hypertensive disorder during 
pregnancy or early postnatal period – regular checkups 
(BP measurement) are required. Specifically at a minimum: 
on Day 1 and once between Day 3 and 5 when the risk of 
adverse cardiovascular event is high [1, 2]; again, at the 6 
week and 3-month postnatal check, and when infants are 
brought for immunization, and at any other contact with 
the health system. Appropriate treatment of hypertension 
postnatally is essential to prevent long-term maternal 
morbidity.
BACKGROUND
Postnatal hypertension is most often caused by high BP 
from pre-eclampsia and gestational hypertension that 
continues after delivery. Pre-eclampsia may develop for 
the first time after childbirth within the first 3-5 days but 
may occur up to 4 weeks postnatal. Evidence suggests 
that about 25% of women with hypertensive disorders in 
pregnancy (HDPs) experience a deterioration of end organ 
function postnatally (period spanning 6–8 weeks after 
delivery).[4] Close BP monitoring after childbirth is highly 
recommended, as 20-44% of maternal deaths occur in 
low resource settings after childbirth [1, 5-9]. In the early 
• The extended postnatal period provides a “window 
of opportunity” to monitor a woman’s BP and to 
check for persistent hypertension. Often women are 
asymptomatic – meaning they are not aware that 
their BP is high.
• If BP is measured routinely at any contact with health 
system during the extended postnatal period – 
hypertension is more likely to be detected and 
managed appropriately.
• Women with pre-eclampsia have a 3.7-fold increased 
risk of future hypertension, 2.2-fold risk of ischemic 
heart disease, and 1.8-fold risk of stroke [3] 
• Measure every woman’s BP after birth, daily until 
discharge. At a minimum on Day 1 and between 
Days 3-5 after birth if discharged early).
• If women continue to have high BP postnatally, they 
must receive hypertensive medicines with close 
follow-up [1,2].
• Women who were previously normotensive during 
pregnancy, may develop hypertension or pre- 
eclampsia for the first time after delivery.
KEY POINTS 
postnatal period, women with pre-existing pre-eclampsia 
who are hospitalized should be considered at high risk for 
complications for at least 3–5 days and should have their 
BP and clinical condition monitored closely [1, 8].
Women with early onset pre-eclampsia (< 34 weeks) and 
gestational hypertension are at higher risk of developing 
persistent cardiovascular impairment 12 months after 
delivery [4]. Pre-eclampsia occurring early in pregnancy or 






















beyond three to six months postnatally suggests possible 
chronic hypertension or renal disease. The risk of chronic 
diseases such as hypertension, ischemic heart disease, 
stroke, renal disease, and diabetes mellitus increases 
in women with pre-eclampsia before 37 weeks or have 
had placental abruption or stillbirth [3]. Higher BMI and 
history of diabetes mellitus is associated with postnatal 
hypertension. It is possible that postnatal hypertension 
represents sub-clinical/asymptomatic or unresolved 
hypertension [10].
Women who have had gestational hypertension or pre-
eclampsia should receive a comprehensive medical 
review within six to eight weeks after delivery, and at 
other contacts with the health system for up to 12 
months, as well as discuss increased lifetime 
cardiovascular risk, anti-hypertensive treatment, and 
risk in future pregnancy [5,8].
Detecting, and/or managing unresolved BP during 
postnatal period is one of several promising high impact 
practices in maternal health. HIPs are identified by a 
technical working group (TWG) of international experts. 
This promising practice has limited evidence, with more 
information needed to fully document implementation 
experience and practice. The TWG advises that these 
practices be promoted widely, provided that they are 
implemented within the context of research and are 
carefully evaluated in terms of both process and impact. 
For more information about other HIPs, see https://www.
popcouncil.org/research/ending-eclampsia1.
WHY IS THIS PRACTICE IMPORTANT?
Hypertension is a leading cause of admission postnatally. 
Early detection prevents complications. Between 
30% and 40% of women who experience eclampsia 
occurs in the postnatal period [11]. In addition to using 
antihypertensives to control high BP, severe pre-eclampsia 
and eclampsia (seizures) are managed using magnesium 
sulphate (MgSO4) [1,2,8].
Hypertension that appears for the first time postnatally 
does so most commonly on days 3–6. Hypertension 
should be recognized and effectively treated to prevent 
increases in severity and to avoid unnecessary delays in 
discharge.
A third of women who have HDPs will have sustained 
hypertension postnatally, although often their BP may 
seem normal in the early postnatal period [12, 13]. 
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Appropriate treatment of postnatal hypertension is 
essential to prevent maternal morbidity and mortality 
from cerebral hemorrhage [12, 13]. 
Hypertensive disorders of pregnancy and the 
postnatal period are associated with several long-term 
complications, including potential complications in future 
pregnancies and a high lifetime risk of cardiovascular 
disease (chronic hypertension, ischemic heart disease, 
stroke, dementia) [1,3].
Definitions: Hypertensive disorders of pregnancy
•  Pre-eclampsia and Eclampsia 
• Pre-eclampsia: Onset of a new episode of 
hypertension after 20 weeks of pregnancy 
or postpartum, characterized by: persistent 
hypertension (systolic BP ≥ 140 mm Hg diastolic 
BP ≥ 90 mm Hg) and substantial proteinuria (> 0.3 
g/24 hours) or any biochemical or hematological 
abnormality.
• Severe pre-eclampsia is pre-eclampsia with 
severe signs and symptoms(severe headache, 
upper abdominal pain, blurred vision, decreased 
urine output)
• Eclampsia: Generalized seizures, in addition to 
pre-eclampsia criteria 
• Gestational hypertension: hypertension (≥140/≥90 
mm Hg) after 20 weeks of pregnancy without 
proteinuria or any biochemical or hematological 
abnormality
• Chronic hypertension: pre-existing high BP (≥140 
mmHg systolic or ≥90 mmHg) before the onset of 
pregnancy or diagnosed in the first 20 weeks of 
gestation
• Hypertension: BP of ≥ 140 mmHg systolic and/or ≥ 
90 mmHg diastolic
• Severe hypertension: BP ≥ 160 mmHg systolic or 
≥110 mmHg diastolic
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CHALLENGES OF ADHERING TO 
RECOMMENDATIONS TO MONITOR BP 
IN POSTNATAL PERIOD
The current World Health Organization (WHO) PNC 
recommendations include close follow up on Day 1 
and 3, within 1 to 2 weeks and again at 6 weeks [14]. 
However, the short time women stay post-delivery in 
health facilities and the poor quality of postnatal contacts 
in many countries reflect the lack of importance given to 
comprehensive PNC [9].
In Nigeria, the national clinical guidelines recommend 
daily BP measurement for the first 3 days after delivery 
for women who suffered from HPD, and at least once 
between days 3–5. In a cohort of 406 women who 
had experienced HPD in eight tertiary health facilities 
in Nigeria, 99% of women had a BP check on the day 
after childbirth. However, adherence progressively 
declined over the next four days, and by the fifth day 
postnatal, BP was only checked in 38% of women [15]. 
In a similar study in Bangladesh, 89% of women with 
HDPs had their BP measured on the first day after giving 
birth, but again by the fifth day BP was only checked in 
16% of women [16]. In Nigeria, the BP of women with 
chronic hypertension remained high (71%) one year after 
childbirth. However, 38%, 36%, and 16% of women with 
gestational hypertension, pre-eclampsia, and eclampsia, 
respectively, also remained hypertensive [15].
WHAT IS THE POTENTIAL IMPACT OF  
IMPLEMENTING PROMISING BEST 
PRACTICES? 
• Early detection and management of hypertension in 
the postnatal period results in timely treatment and 
follow up
• Women are more aware of the long-term health 
implications resulting in improved health literacy
• Women with non-communicable disease may be better 
prepared for a future pregnancy
• Potentially expediated reduction in maternal morbidity 
and mortality
Women at risk of developing postnatal  
hypertension (Smith et al 2013)
• Preterm delivery triggered by  
maternal hypertensive disease
• Hypertension requiring 
antenatal treatment





HOW TO DO IT: TIPS FROM  
IMPLEMENTATION EXPERIENCE
Based on programmatic experience, the following 
strategies can help facilitate successful monitoring of 
BP in the extended postnatal period to improve early 
detection and management of  hypertension. 
• Consider the context and level of health facility and 
skills of different cadres. Recognize skills mix  of 
available health care providers. Community health 
workers (CHWs) can provide information to women 
and families on postnatal complications. Lower level 
providers (including CHWs) are capable of measuring 
BP, and primary health care (PHC) providers can 
manage/refer women with hypertensive disorders 
in the postnatal period (including administration of 
MgSo4).
POSTNATAL PERIOD (0-6 WEEKS)
• Women with HDPs should be automatically referred to 
physician/specialist for follow-up
• Review international guidelines on HDPs in PNC and 
adapt country level guidelines and protocols for health 
workers. Follow WHO recommendations for PNC 
contacts: measure BP immediately after birth,  3-7 
4
days, 2 weeks and 6 weeks after birth and any future 
contact with the health system [1, 2] 
• PNC should be an ongoing process rather than a single 
encounter, and all women should have contact with 
health system within the first three weeks postnatal 
and beyond [1, 14, 17] 
• Develop PNC protocols for all recommended contacts 
and ensure protocols include monitoring of BP and 
management of hypertension
• If there is no Group ANC model in place, consider 
extending to Group PNC – this provides peer support 
to continue to monitor BP into the extended PNC 
period.  If no Group ANC consider initiating a “Mothers 
and Baby’s club” at community level.
EXTENDED POSTNATAL PERIOD (6 
WEEKS TO 12 MONTHS)
• After 6 weeks, use every contact that a woman has 
with the health system to reduce missed opportunities 
to check their BP. Such instances include when 
bringing their baby for check-ups, growth monitoring, 
immunizations and for postnatal family planning.
• Integrate services with primary care to ensure 
seamless transition for care throughout the life 
course. At any facility contact beyond 6 months 
monitor BP if previously high and referral to 
physicians. It is important  to consider continuous 
family care or life cycle approach [18]
PATIENT LITERACY 
• Counsel women treated for HDPs about increased 
risk of future heart disease. Advise women about 
future pregnancy risks and health and the need for 
routine BP checks.
• Challenges in health-seeking behavior in the 
postnatal period need to be addressed. Women with 
pregnancy and postnatal complications and their 
families require more information to enable them 
to be aware of potential future health complications 
and why they should attend follow-up consultations 
and ask for BP checks.
• Identify opportunities to discuss with communities 
the risks in future pregnancies and long-term health 
risks  for women with HDPs, and find ways to bring 
them for follow-up or how to increase efficiency of the 
service providers for effective counseling. 
FACTORS THAT INHIBIT SUCCESS 
• Policy factors: There are notable inconsistencies 
on when to measure BP and how to manage 
hypertension in both the immediate and extended 
postnatal period at global and national levels [19].
• Structural drivers: Poor procurement processes; 
one BP cuff shared between ANC, labor and delivery 
and other departments; and poor quality of BP 
measurement tools, including a lack of validated 
BP measurement machines, cuffs and stethoscope; 
limited awareness of all cadres of health providers on 
importance of routine BP measurement; limited skills 
updates; staff shortages; and frequent turnover.
• Poor coordination or lack of teamwork between 
PHC level, midwives, obstetricians, and physicians, 
resulting in women getting lost in the system.
• There is a lack of policy guidelines for task sharing 
related to measuring and managing high BP, 
conducting comprehensive care, and treating 
hypertension, including administering loading dose 
of MgSO4 and antihypertensives.
• Women leave health facilities soon after birth and do 
not complete recommended PNC contacts (including 
BP measurement and management) due to lack of 
awareness of risks.
PRIORITY RESEARCH AREAS  
• What is driving the increase in postnatal pre-eclampsia/
eclampsia?
• Linking pre-eclampsia and gestational hypertension 
to NCDs in lower middle income countries: long term 
effect and survival re women getting the right care; 
maternal mental health (postpartum depression, 
anxiety, and PTSD) linked to HDPs.
• How to best deliver postpartum cardiovascular risk 
reduction programs in lower middle income countries
• What is the ideal duration of MgSO4 as an 
anticonvulsant postnatally?
• Large longitudinal cohorts to embrace “Fourth 
Trimester” using a life course perspective
• Evaluate intervention and review plans for scale up 
and scalability 
INDICATORS FOCUSING ON PRE- 
ECLAMPSIA AND BP: FROM WHO  
STANDARDS OF MNH QOC
• The proportion of all women in PNC wards or areas 
in the health facility who have documented problems 
of BP, pulse rate, vaginal bleeding, lochia or 
breastfeeding. (84.02)
• The health facility has functioning essential 
equipment and supplies for the detection of 
complications (e.g. thermometers, sphygmomano-
meters, fetal stethoscopes, urine dipsticks, pulse 
oximeter) in sufficient quantities at all times in the 
labour and childbirth areas of the maternity unit. 
(91.63)
• The health facility has written, up-to-date clinical 
protocols on the management of pre-eclampsia that 
are available in the labour, childbirth and postnatal 
areas and are consistent with WHO guidelines. 
(90.59)
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Recommendations on measuring BP and managing 
hypertension postnatally. 
• Measure BP after birth, [1,2] and continued daily till 
discharge [1].
• Provide close postnatal follow up until BP continues 
to be normal/returns to normal or is managed 
appropriately. 
• Treat women with antihypertensive drugs in the 
postnatal period if they: (1) have severe hypertension; 
or (2) were treated with antihypertensive drugs 
during pregnancy [2]. Keep BP at less than 
160/110mmHg. Further investigation is required 
if hypertension persists beyond three months [1]. 
(ISSHP 2018). 
• Review women’s risk factors on discharge (and at 
subsequent PNC contacts), and inform women with 
HDPs of the risk of recurrence in future pregnancies 
[8] and future cardiovascular risks [12]. 
• Review all women at 3 months postnatal by which 
time BP, urinalysis, and laboratory tests should 
have normalized [1]. If these indicators haven’t 
normalized, refer to physicians as appropriate.
• Develop and strengthen postnatal policy/protocols 
to ensure women who experienced pre-eclampsia/
eclampsia are followed up. This includes providing 
a client held “HDP card” to record her BP and other 
tests during the extended postnatal period.
• Health-care staff in the maternity unit receive in- 
service training and regular refresher sessions in the 
use of antihypertensive agents, intravenous infusion 
and MgSO4 for treating pre-eclampsia and eclampsia 
at least once every 12 months. (84.54)
• The proportion of all women discharged postpartum 
within the past 24 hours had an accurately 
completed record of processes of care, treatments, 
outcomes and diagnoses (with ICD code). (82.88)
• The health facility has supplies of antihypertensive 
agents and MgSO4 (and the antidote calcium 
gluconate) in sufficient quantities, available at all 
times, in antenatal, labour, childbirth and postnatal 




• ISSHP Classification, Diagnosis, and Management 
Recommendations for International Practice
• Nathan HL, Duhig K, Hezelgrave NL, Chappell LC, 
Shennan AH. Blood pressure measurement in 
pregnancy. The Obstetrician & Gynaecologist 2015; 
17:91–8.
• NICE Hypertension in pregnancy: diagnosis and 
management guideline [NG133] NHS UK 2019
• World Health Organization. WHO recommendations 
for the prevention and treatment of pre-eclampsia/
eclampsia. Geneva; 2011 http://apps.who.int/iris/ 
bitstream/10665/44703/1/9789241548335_eng.
pdf
• World Health Organization. WHO recommendations 




• WHO 2016 Standards for improving quality of 
maternal and newborn care in health facilities WHO 
2017 Managing Complications in Pregnancy and 
Childbirth (MCPC): A Guide for Midwives and Doctors 
second edition.
• WHO Integrating Management of Pregnancy and 
Childbirth (IMPAC):  2017 Consider highlighting 
aspects of IMPAC related to integration with 
immunization/child health services related to 
reducing missed opportunities for women’s checkups 
in the postnatal period.
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